Holen Sie sich die Stockscreener-App
88.92
2.02%
1.7577
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$87.16
Offen:
$87.16
24-Stunden-Volumen:
2.82M
Relative Volume:
0.29
Marktkapitalisierung:
$113.82B
Einnahmen:
$36.36B
Nettoeinkommen (Verlust:
$4.84B
KGV:
23.86
EPS:
3.7261
Netto-Cashflow:
$5.43B
1W Leistung:
+2.58%
1M Leistung:
+6.02%
6M Leistung:
-12.32%
1J Leistung:
-4.26%
1-Tages-Spanne:
$86.72
$89.03
1-Wochen-Bereich:
$84.95
$89.03
52-Wochen-Spanne:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
88.92 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
ABT
Abbott Laboratories
|
108.79 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
342.58 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
50.69 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.34 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Fortgesetzt | Barclays | Overweight |
| 2026-02-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Medtronic Rises as Investors Weigh Growth Momentum and Deal Activity - Quiver Quantitative
UBS Upgrades Medtronic to Buy From Neutral, Raises Price Target to $100 From $85 - marketscreener.com
Medtronic Stock Steadies As AI, SPR Deal And Reimbursement Catalysts Build - timothysykes.com
Medtronic Stock Builds Momentum On AI, SPR Deal And Bullish Street - StocksToTrade
Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance - GlobeNewswire Inc.
Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall? - Yahoo Finance
Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte - Yahoo Finance UK
Medtronic PLC (MDT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low - Yahoo Finance UK
Is Medtronic (MDT) Undervalued Following Its Pediatric Cannula Recall? - simplywall.st
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance Singapore
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic PLC (MDT) Cash Flow - TradingKey
Medtronic PLC (MDT) Balance Sheet - TradingKey
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - Stock Traders Daily
Medtronic continues assembly of industry’s “broadest” pain therapy portfolio - Medical Device Network
MDT|Medtronic PLC|Price:87.213|Chg%:+2.993 - TradingKey
Medtronic stock steadies as diabetes and cardiac businesses underpin earnings - AD HOC NEWS
Medtronic (NYSE:MDT): A Value Stock with a Discounted Valuation and Accelerating Growth - ChartMill
Medtronic PLC (MDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medtronic PLC (MDT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDT|Medtronic PLC|Price:83.500|Chg%:+0.290 - TradingKey
MicroPort MedBot To Report First-Ever Profit On Booming Exports - Benzinga
Medtronic PLC (MDT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
Medtronic PLC (MDT) Institutional Confidence - TradingKey
Medtronic stock trades steadily as recent earnings and diabetes device momentum shape investor view - AD HOC NEWS
Medtronic stock trades steady as diabetes segment grows and guidance holds - Ad-hoc-news.de
Medtronic Earnings Preview: What to Expect - Yahoo Finance
Medtronic to launch AI compute platform for the operating room - The Robot Report
Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot - Seeking Alpha
Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms - Yahoo Finance
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - Investing News Network
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Singapore
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic adds real-time AI to Hugo robot - MedTech Dive
Medtronic stock trades steady as diabetes and cardiovascular revenue support margins - Ad-hoc-news.de
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - BioSpace
Medtronic declares Q2 2026 dividend of R$ 1.33 per unit - Bitget
Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18 - GuruFocus
Medtronic to announce financial results for its first quarter of fiscal year 2027 - Investing News Network
Medtronic to report Q1 FY2027 financial results on September 1, 2026 - Pluang
Medtronic sets Sept. 1 date for its next financial report - Stock Titan
Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios - Today's Medical Developments
Medtronic stock holds steady as diabetes and cardiovascular growth underpin recent earnings - ad-hoc-news.de
Medtronic acquires SPR Therapeutics for USD 650 million - Medical Buyer
Medtronic : and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - marketscreener.com
Medtronic completes SPR Therapeutics acquisition - MedTech Dive
Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care - Yahoo Finance
Medtronic stock trades steadily as diabetes and cardiovascular businesses support earnings - ad-hoc-news.de
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - Big News Network.com
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):